Resverlogix Competitors and Similar CompaniesClear all
Resverlogix's competitors and similar companies include CRISPR Therapeutics.
 Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. | |
Founding Date | Founding Date 2001 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Calgary, CA HQ San Francisco, US | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US |
Employees | Employees 19 | Employees 393 |
Valuation ($) | Valuation ($) 12.9 m | Valuation ($) 4.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income ($7.8m) (FY, 2025) | Net income ($581.6m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 10m | Total funding raised $ 127m |
For sources of this data, please see the company profile
View Company Profiles
CRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company